We are live on ! Find out more
ARMC

American Research & Management Company Portfolio holdings

AUM $362M
1-Year Est. Return 8.06%
This Fund
S&P 500
This Quarter Est. Return
+1.75%
1 Year Est. Return
-8.06%
3 Year Est. Return
+35.06%
5 Year Est. Return
+60.88%
10 Year Est. Return
–
AUM
$288M
AUM Growth
-$16.7M
Cap. Flow
-$20.4M
Cap. Flow %
-7.08%
Top 10 Hldgs %
36.94%
Holding
381
New
20
Increased
53
Reduced
63
Closed
59

Top Buys

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$5.5M
2
CHX
ChampionX
CHX
+$1.55M
3
PEP icon
PepsiCo
PEP
+$1.39M
4
AMZN icon
Amazon
AMZN
+$1.33M
5
EW icon
Edwards Lifesciences
EW
+$1.1M

Top Sells

Rank Stock Value
1
WFC.PRJ.CL
Wells Fargo & Company
WFC.PRJ.CL
+$3.83M
2
USB.PRM
U.S. Bancorp Depositary Shares, each representing 1/1000th interest in a share of Series F Non-Cumul
USB.PRM
+$2.31M
3
DOV icon
Dover
DOV
+$1.43M
4
BPFHP
Boston Private Financial Holdings, Inc.
BPFHP
+$1.22M
5
BBT.PRE.CL
BB&T Corporation Depositary Shares each representing 1/1,000th interest in a share of Series E Non-C
BBT.PRE.CL
+$1.06M

Sector Composition

Rank Sector Weight
1 Technology 26.89%
2 Healthcare 16.4%
3 Consumer Staples 14.86%
4 Financials 11.57%
5 Energy 10.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WLY icon
26
John Wiley & Sons Class A
WLY
$2.73B
$3.32M 1.15%
53,240
-70
-0.1% -$4.65K
KO icon
27
Coca-Cola
KO
$386B
$3.17M 1.1%
72,177
+19,200
+36% +$829K
SYK icon
28
Stryker
SYK
$127B
$3.08M 1.07%
18,225
-2,800
-13% -$471K
BIIB icon
29
Biogen
BIIB
$32.3B
$3M 1.04%
10,355
+1,145
+12% +$322K
MSFT icon
30
Microsoft
MSFT
$3.81T
$2.78M 0.96%
28,160
-580
-2% -$56.2K
TFX icon
31
Teleflex
TFX
$5.92B
$2.73M 0.95%
10,159
-150
-1% -$40.2K
TD icon
32
Toronto Dominion Bank
TD
$199B
$2.69M 0.94%
46,536
– –
MKC icon
33
McCormick & Company Non-Voting
MKC
$14.9B
$2.6M 0.9%
44,820
+3,750
+9% +$197K
DD icon
34
DuPont de Nemours
DD
$18.5B
$2.55M 0.89%
15,282
-1,926
-11% -$322K
HP icon
35
Helmerich & Payne
HP
$4.25B
$2.55M 0.89%
39,960
+9,945
+33% +$677K
RTX icon
36
RTX Corp
RTX
$285B
$2.29M 0.8%
29,134
+5,720
+24% +$448K
TRP icon
37
TC Energy
TRP
$64.4B
$2.28M 0.79%
52,829
-5,800
-10% -$246K
AMZN icon
38
Amazon
AMZN
$2.87T
$2.01M 0.7%
23,700
+16,780
+242% +$1.33M
BRK.B icon
39
Berkshire Hathaway Class B
BRK.B
$1.08T
$2M 0.69%
10,695
-250
-2% -$48.7K
CELG
40
DELISTED
Celgene Corp
CELG
$1.99M 0.69%
25,015
+2,770
+12% +$230K
GILD icon
41
Gilead Sciences
GILD
$181B
$1.95M 0.68%
27,480
+5,530
+25% +$391K
VRTX icon
42
Vertex Pharmaceuticals
VRTX
$137B
$1.89M 0.66%
11,100
+2,000
+22% +$310K
MRK icon
43
Merck
MRK
$366B
$1.77M 0.61%
30,529
-2,381
-7% -$134K
PFE icon
44
Pfizer
PFE
$159B
$1.67M 0.58%
48,383
+16,612
+52% +$568K
MAR icon
45
Marriott International
MAR
$91.5B
$1.59M 0.55%
12,532
-216
-2% -$29.4K
CHX
46
DELISTED
ChampionX
CHX
$1.58M 0.55%
+37,914
New +$1.55M
LQD icon
47
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.9B
$1.56M 0.54%
13,610
-50
-0.4% -$5.76K
FFIV icon
48
F5
FFIV
$22.3B
$1.5M 0.52%
8,705
-3,030
-26% -$505K
HCI icon
49
HCI Group
HCI
$2.32B
$1.48M 0.52%
35,700
+1,550
+5% +$64.1K
RMD icon
50
ResMed
RMD
$34.7B
$1.41M 0.49%
13,615
+130
+1% +$13.2K
1
2
3 4 5

Similar funds

BPM
Bowling Portfolio Management Cincinnati, Ohio $364M AUM 7.07% 1-Year Est. Return
S
Surevest Los Angeles, California $368M AUM 13.7% 1-Year Est. Return
ACM
Axar Capital Management New York $304M AUM 38.78% 1-Year Est. Return
GMA
Goldstein Munger & Associates San Ramon, California $303M AUM 19.66% 1-Year Est. Return
AW
ACG Wealth Atlanta, Georgia $437M AUM 11.28% 1-Year Est. Return
RFA
Radnor Financial Advisors Wayne, Pennsylvania $284M AUM 23.21% 1-Year Est. Return
AIA
AGF Investments America Toronto, Ontario, Canada $271M AUM 7.04% 1-Year Est. Return
SMG
Spectrum Management Group Indianapolis, Indiana $460M AUM 10.37% 1-Year Est. Return

American Research & Management Company's Q2 2018 Portfolio in Review

As of Q2 2018, American Research & Management Company held 381 positions worth $288M, down 5.5% from $305M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

American Research & Management Company withdrew a net $20.4M in Q2 2018, closing 59 positions and reducing 63 holdings. Its most notable exit was Wells Fargo & Company, an estimated $3.83M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Staples.

Against the trend, American Research & Management Company opened a new position in Procter & Gamble worth $5.7M.

  • American Research & Management Company's largest Q2 2018 buy was Procter & Gamble: 73,027 shares worth $5.7M.
  • American Research & Management Company added most to PepsiCo in Q2 2018, an estimated $1.39M increase.
  • American Research & Management Company's biggest Q2 2018 reduction was Dover, cutting an estimated $1.43M.
  • American Research & Management Company fully exited Wells Fargo & Company in Q2 2018, selling an estimated $3.83M.
  • American Research & Management Company's ten largest holdings make up 37% of its $288M portfolio in Q2 2018.
  • American Research & Management Company opened 20 new positions and closed 59 in Q2 2018.
  • American Research & Management Company's portfolio value fell 5.5% quarter-over-quarter to $288M.

Based on American Research & Management Company's 13F filing for Q2 2018, filed 25 Jul 2018.